Table 2.
Characteristics of anxiety, depression, and anger symptoms according to the HADS-M questionnaire in the present study, with evaluation of the variability significance.
| Experimental group (EMDR) |
Control group |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| T0 (mean ± SD) | T1 (mean ± SD) | Student’s t | P | Wilcoxon test | T0 (mean ± SD) | T1 (mean ± SD) | Student’s t | P | Wilcoxon test | |
| Anxiety | 17.50 ± 2.36 | 9.89 ± 3.79 | 8.971 | 0.000 | p < 0.000 | 13.16 ± 3.61 | 14.89 ± 3.25 | -2.049 | 0.055 (n.s.) | p < 0.048 |
| Depression | 16.44 ± 4.03 | 7.56 ± 3.78 | 9.574 | 0.000 | p < 0.000 | 10.79 ± 4.37 | 13.68 ± 3.19 | -2.740 | 0.013 | p < 0.016 |
| Anger | 3.39 ± 1.46 | 1.72 ± 0.96 | 4.123 | 0.001 | p < 0.004 | 2.58 ± 1.17 | 2.36 ± 1.11 | 0.889 | 0.385 (n.s.) | p < 0.417 (n.s.) |
EMDR, eye movement desensitization and reprocessing; T0, first measurement; T1, second measurement, after therapy (in experimental group) or after 14 weeks (in control group); n.s., not significant.